PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40125P00297FDA clinical trials.gov reporting &asd research — Insilica LLC

Insilica LLC holds $1.2M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs

Awarding office

Insilica LLC

Recipient

Sep 29, 2026

PoP end

$1.3M

Obligated

$2.5M

Potential

518210

NAICS

DH01

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Insilica LLC — $90

Contract facts

NONE

Contract number75F40125P00297

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentInsilica LLC

CAGE7RTE5

UEIRTN8V2BMGY63

NAICS518210

No full NAICS 518210 intel page yet. Browse NAICS intelligence

PSCDH01

Place of performanceSILVER SPRING MD

Pricing typeFirm Fixed Price

Extent competedNot Available For Competition

PoP startSep 29, 2025

PoP end (current)Sep 29, 2026

PoP end (w/ options)Sep 29, 2027

Obligated$1.3M

Current value$1.3M

Potential value$2.5M

FDA CLINICAL TRIALS.GOV REPORTING &ASD RESEARCH PROGRAM - SBIR III is a federal NONE award for Fda Office Of Acq Grant Svcs held by Insilica LLC. Estimated value $2.5M ($1.3M obligated). Current period of performance ends Sep 29, 2026 (potential Sep 29, 2027). Last award drew 1 bidder. Place of performance: SILVER SPRING MD.

FDA CLINICAL TRIALS.GOV REPORTING &ASD RESEARCH PROGRAM - SBIR III

Recompete timing

Public

● Expiring in 22 days

Current PoP ends Sep 29, 2026 (22 days remaining). Agencies typically plan 12–18 months ahead — at 0.7 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Insilica LLC — $1.2M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$1.2M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40125P00297?

75F40125P00297 (FDA clinical trials.gov reporting &asd research) is a Fda Office Of Acq Grant Svcs award with a potential value of $2.5M, currently held by Insilica LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40125P00297?

Fda Office Of Acq Grant Svcs awarded 75F40125P00297 to Insilica LLC (potential $2.5M).

Who is the incumbent on 75F40125P00297?

Insilica LLC is the incumbent with $1.2M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does Insilica LLC’s 75F40125P00297 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75F40125P00297 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Sep 29, 2025